ZEB1 is a known driver of epithelial-to-mesenchymal transition (EMT), a phenotype associated with cancer cells that are typically prone to metastasis, drug resistance and poor clinical outcome, and which represent potential therapeutic targets for cancer progression. The gene discussed is ZEB1; the disease is cancer.